|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-5-4
|
|
pubmed:abstractText |
Individuals with end-stage renal disease (ESRD) are 10- to 25-fold more likely than immunocompetent people to develop active tuberculosis (TB) and are candidates for being treated for latent TB infection (LTBI). However, diagnosis using the tuberculin skin test (TST) is doubly difficult due to cutaneous anergy and cross-reactions with Bacille-Calmette-Guérin (BCG) vaccination.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1439-0973
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
96-102
|
|
pubmed:meshHeading |
pubmed-meshheading:19139810-Adult,
pubmed-meshheading:19139810-Aged,
pubmed-meshheading:19139810-Chi-Square Distribution,
pubmed-meshheading:19139810-Cohort Studies,
pubmed-meshheading:19139810-Female,
pubmed-meshheading:19139810-Humans,
pubmed-meshheading:19139810-Immunoenzyme Techniques,
pubmed-meshheading:19139810-Interferon-gamma,
pubmed-meshheading:19139810-Kidney Failure, Chronic,
pubmed-meshheading:19139810-Logistic Models,
pubmed-meshheading:19139810-Male,
pubmed-meshheading:19139810-Middle Aged,
pubmed-meshheading:19139810-Mycobacterium tuberculosis,
pubmed-meshheading:19139810-Prospective Studies,
pubmed-meshheading:19139810-Recurrence,
pubmed-meshheading:19139810-Renal Dialysis,
pubmed-meshheading:19139810-Tuberculin Test,
pubmed-meshheading:19139810-Tuberculosis
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test.
|
|
pubmed:affiliation |
Dept. of Medicine, Kaohsiung Veterans General Hospital, Taiwan. ssjlee28@yahoo.com.tw
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
